SNN logo

SNN Smith & Nephew plc

New York Stock Exchange · Medical - Devices · Healthcare

$29.83
+0.00 (+0.00%)

Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for joint reconstruction. This segment also provides trauma and extremities products, including internal and external fixation devices crucial for stabilizing severe fra…

Market Cap: $12.48Bwww.smith-nephew.com

Price

$30.11-3.37%
$28.73$30.04$31.35$32.66
May 1Aug 7

Social Signal Score

52
5d
—
30d
51
3 mentions
+0.0%
60d
53
8 mentions
+0.0%
90d
53
12 mentions
+0.0%
news: 12

Analyst Ratings

23 analysts
Holdconsensus
Strong Buy 0Buy 6Hold 15Sell 2Strong Sell 0
Avg price target$33.88+13.6%
Low $33.88Median $33.88High $33.88
Current Consensus

Revenue

$3.10B+128.06%
$1.18B$1.85B$2.53B$3.20B
Dec 2006Jun 2026

Analyst Estimates

FY2025
$1.99
$1.94–$2.04
3 analysts
FY2026
$2.13+7% YoY
$2.12–$2.15
2 analysts
FY2027
$2.30+8% YoY
$2.28–$2.32
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Deepak S. Nath
Sector
Healthcare
Industry
Medical - Devices
Employees
18,362
Beta
0.69
Country
GB
Piotroski score
8 / 9 (Strong)
Altman Z-score
3.07
www.smith-nephew.com